Finance

Lists
UTHR:NASDAQ
United Therapeutics Corp
554,73 $
-0,78%
(-4,37) 1D
550,23 $
-0,81% (-4,50)
After hours
Closed: 20 նոյ, 16:00:01 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for UTHR...
Open
561,20 $
High
563,12 $
Low
551,76 $
Mkt. cap
23,63 մլրդ
Avg. vol.
543,11 հզր
Volume
355,14 հզր
P/E ratio
20,93
52-wk high
614,23 $
52-wk low
455,63 $
EPS
26,51 $
Beta
0,49
Shares outstanding
42,59 մլն
No. of employees
1 հզր
Open
561,20 $
High
563,12 $
Low
551,76 $
Mkt. cap
23,63 մլրդ
Avg. vol.
543,11 հզր
Volume
355,14 հզր
P/E ratio
20,93
52-wk high
614,23 $
52-wk low
455,63 $
EPS
26,51 $
Beta
0,49
Shares outstanding
42,59 մլն
No. of employees
1 հզր
News stories
From web sources and news partners
Profile
United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire. Wikipedia
About United Therapeutics Corp
CEO-
Employees1,4 հզր
Founded1996
HeadquartersՍիլվեր Սփրինգ, Մերիլենդ, Միացյալ Նահանգներ
SectorHealth Care
Industry-
Analyst ratings
Based on 14 analysts giving stock ratings to UTHR in the past 3 months
Buy
Buy
11
Hold
2
Sell
1
12-month forecast
Based on 14 Wall Street analysts offering 12 month price targets for UTHR in the last 3 months.
Highest
Current 554,73 $
850,00 $ (+53,23%)
Average
682,71 $ (+23,07%)
Lowest
368,00 $ (-33,66%)
Analyst
Recommendation
Action
Price target
Projected
Date
Matthew Caufield
H.C. Wainwright
Buy
Initiated
660,00 $
+19%
11/09/2026
Roanna Ruiz
Leerink Partners
Buy
Reiterated
725,00 $
+30,7%
11/05/2026
Joseph Thome
TD Cowen
Buy
Reiterated
700,00 $
+26,2%
11/05/2026
Terence Flynn
Morgan Stanley
Hold
Reiterated
568,00 $
+2,4%
11/05/2026
Lisa Walter
RBC Capital
Buy
Reiterated
725,00 $
+30,7%
11/04/2026
Julian Harrison
BTIG
Buy
Maintained
768,00 $
+38,4%
11/04/2026
Benjamin Burnett
Wells Fargo
Buy
Reiterated
703,00 $
+26,7%
11/05/2026
Jason Gerberry
Bank of America Securities
Hold
Maintained
650,00 $
+17,2%
11/04/2026
Jessica Fye
J.P. Morgan
Buy
Reiterated
695,00 $
+25,3%
10/28/2026
Olivia Brayer
Cantor Fitzgerald
Buy
Maintained
850,00 $
+53,2%
10/26/2026
Tiago Fauth
Raymond James
Buy
Maintained
717,00 $
+29,3%
10/20/2026
Andrea Newkirk
Goldman Sachs
Sell
Maintained
368,00 $
-33,7%
10/15/2026
Ashwani Verma
UBS
Buy
Maintained
725,00 $
+30,7%
10/13/2026
Roger Song
Jefferies
Buy
Maintained
704,00 $
+26,9%
10/01/2026
Andrew Fein
H.C. Wainwright
Buy
Maintained
660,00 $
+19%
08/06/2026
Unknown Analyst
J.P. Morgan
Buy
Maintained
685,00 $
+23,5%
05/20/2026
Unknown Analyst
Raymond James
Buy
Initiated
700,00 $
+26,2%
04/09/2026
Andreas Argyrides
Oppenheimer
Buy
Maintained
650,00 $
+17,2%
03/12/2026
Jasper Hellweg
Argus Research
Buy
Reiterated
560,00 $
+1%
03/03/2026
Last report
2026 թ. նոյ 4
Fiscal period
Q3 2026
5,71 $ / 6,34 $
-9,97%miss
Revenue / Est. (USD)
832,50 մլն / 781,14 մլն
+6,57%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
2026 թ. սեպ
Revenue
790,20 մլն
781,50 մլն
783,30 մլն
832,50 մլն
Cost of goods sold
103,40 մլն
133,40 մլն
99,50 մլն
99,10 մլն
Cost of revenue
103,40 մլն
133,40 մլն
99,50 մլն
99,10 մլն
Research and development expenses
139,50 մլն
138,20 մլն
146,30 մլն
279,20 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
189,90 մլն
184,10 մլն
206,70 մլն
212,90 մլն
Operating expense
329,40 մլն
322,30 մլն
353,00 մլն
492,10 մլն
Total operating expenses
432,80 մլն
455,70 մլն
452,50 մլն
591,20 մլն
Operating income
357,40 մլն
325,80 մլն
330,80 մլն
241,30 մլն
Other non operating income
800,00 հզր
15,30 մլն
-100,00 հզր
15,00 մլն
EBT including unusual items
444,00 մլն
318,30 մլն
372,70 մլն
372,80 մլն
EBT excluding unusual items
398,30 մլն
379,90 մլն
359,30 մլն
287,10 մլն
Income tax expense
79,70 մլն
43,40 մլն
39,70 մլն
114,20 մլն
Effective tax rate
17,95%
13,63%
10,65%
30,63%
Other operating expenses
-
-
-
-
Net income
364,30 մլն
274,90 մլն
333,00 մլն
258,60 մլն
Net profit margin
46,10%
35,18%
42,51%
31,06%
Earnings per share
7,70
5,82
7,27
5,71
Interest and investment income
43,20 մլն
41,80 մլն
31,50 մլն
33,70 մլն
Interest expense
-3,10 մլն
-3,00 մլն
-2,90 մլն
-2,90 մլն
Net interest expenses
40,10 մլն
38,80 մլն
28,60 մլն
30,80 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
380,20 մլն
348,40 մլն
355,00 մլն
267,70 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google Apps